FDA Says Gout Drug Uloric Has Increased Death Risk Compared To Alternative
(February 25, 2019, 1:30 PM EST) -- SILVER SPRING, Md. — The Food and Drug Administration on Feb. 21 said it concluded that there is an increased risk of death from the use of Uloric brand febuxostate to...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login